Cyclacel Pharmaceuticals Beheer
Beheer criteriumcontroles 3/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Spiro Rombotis
Algemeen directeur
US$661.0k
Totale compensatie
| Percentage CEO-salaris | 84.7% |
| Dienstverband CEO | 27.3yrs |
| Eigendom CEO | 1.5% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 8.2yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$18m |
| Mar 31 2024 | n/a | n/a | -US$20m |
| Dec 31 2023 | US$661k | US$560k | -US$23m |
| Sep 30 2023 | n/a | n/a | -US$25m |
| Jun 30 2023 | n/a | n/a | -US$24m |
| Mar 31 2023 | n/a | n/a | -US$23m |
| Dec 31 2022 | US$764k | US$546k | -US$21m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$19m |
| Mar 31 2022 | n/a | n/a | -US$20m |
| Dec 31 2021 | US$1m | US$531k | -US$19m |
| Sep 30 2021 | n/a | n/a | -US$20m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$1m | US$531k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Jun 30 2020 | n/a | n/a | -US$8m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | US$1m | US$531k | -US$8m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$8m |
| Mar 31 2019 | n/a | n/a | -US$8m |
| Dec 31 2018 | US$753k | US$531k | -US$7m |
| Sep 30 2018 | n/a | n/a | -US$8m |
| Jun 30 2018 | n/a | n/a | -US$14m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$776k | US$531k | -US$15m |
Compensatie versus markt: Spiro's total compensation ($USD661.05K) is about average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Spiro's compensation has been consistent with company performance over the past year.
CEO
Spiro Rombotis (65 yo)
27.3yrs
Tenure
US$661,049
Compensatie
Mr. Spiro George Rombotis has been President of Cyclacel Pharmaceuticals Inc. (formerly, Cyclacel Pharmaceuticals, Inc. (formerly known as Cyclacel Group plc)) since August 1997 and has been its Founding C...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 18.7yrs | US$661.05k | 1.52% $ 18.8k | |
| Executive VP of Finance | 18.7yrs | US$352.62k | 0.82% $ 10.2k | |
| Chief Medical Officer & Director | 3.9yrs | US$84.49k | 0.85% $ 10.5k | |
| Independent Chair of the Board | 10.2yrs | US$97.99k | 0.21% $ 2.6k | |
| Independent Director | 18.7yrs | US$136.99k | 0.21% $ 2.6k | |
| Independent Director | 4yrs | US$95.49k | 0.21% $ 2.6k | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Vice Chairman | 6.2yrs | US$115.99k | 0.21% $ 2.6k | |
| Independent Director | 2.4yrs | US$85.49k | 0.20% $ 2.4k |
8.2yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: CYCC.P's board of directors are considered experienced (8.2 years average tenure).